Yahoo Canada Web Search

Search results

    • Analysts Hunt for Undervalued Biotech Stocks

      Digital Journal· 16 hours ago

      (NASDAQ: CTXR), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products. The Company< ...

    • Wednesday’s analyst upgrades and downgrades

      Wednesday’s analyst upgrades and downgrades

      The Globe and Mail· 19 hours ago

      A “material” increase in gold and silver prices is likely to translate to higher free cash flow and “trending balance sheet improvements” for Canadian...